# PMT for MDRO Decolonization

> **NCT05632315** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 32 (actual)

## Conditions studied

- Multidrug Resistant Bacterial Infection
- Enterobacteriaceae Infections
- Pseudomonas Aeruginosa
- VRE Infection
- Methicillin-resistant Staphylococcus Aureus

## Interventions

- **DRUG:** PMT

## Key facts

- **NCT ID:** NCT05632315
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-19
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05632315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05632315, "PMT for MDRO Decolonization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05632315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*